Examining vein wall thickness and inflammation in Behçet disease patients
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
This study looks at the thickness of vein walls and signs of inflammation in adults with Behçet disease to see how these factors relate to the disease's activity and symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 19 Years to 80 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06721234 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the thickness of the femoral vein wall and inflammatory markers in patients diagnosed with Behçet disease. It aims to assess the relationship between these factors and the activity of the disease, as well as associated clinical manifestations. The study includes adult patients who meet the International Criteria for Behçet's Disease and are able to provide informed consent. By analyzing these parameters, the study seeks to enhance understanding of the disease's impact on vascular health.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with Behçet disease according to established criteria.
Not a fit: Patients with other rheumatological or vascular diseases, or those with significant comorbidities such as hypertension or diabetes, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the vascular complications of Behçet disease, potentially leading to improved management strategies.
How similar studies have performed: While there may be limited studies specifically focusing on vein wall thickness in Behçet disease, similar research on inflammatory markers has shown promising results in understanding disease mechanisms.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients fulfill the International Criteria for Behcet's Disease (ICBD) * Age above 18 years old * Patients cooperative and can answer questions * Patients who are able and willing to give informed consent Exclusion Criteria: * Other rheumatological and vascular diseases * Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests * Patients with hypertension , diabetes mellitus , malignant and active infectious diseases * Patients who are using aspirin and other platelet active drygs during the previous 6 months * patients who are not able and willing to give written consent
Where this trial is running
Sohag
- Sohag university — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Engy L Fawzy
- Email: engylouisfawzey@gmail.com
- Phone: 01282665433
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.